Allen Nissenson

CIK: 0001441889

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ELTX

Elicio Therapeutics, Inc.

Director

RMTI

ROCKWELL MEDICAL, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ELTX
Elicio Therapeutics, Inc.
Aug 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
21.8K shares-
RMTI
ROCKWELL MEDICAL, INC.
Jul 1, 2026
Award(A)
Direct
9.6K shares-
RMTI
ROCKWELL MEDICAL, INC.
May 20, 2025
Award(A)
Direct
50K shares-
ELTX
Elicio Therapeutics, Inc.
May 19, 2025
Award(A)
Stock Option (Right to Buy)
Direct
7.9K shares-
ELTX
Elicio Therapeutics, Inc.
Nov 21, 2024
Award(A)
Stock Option (Right to Buy)
Direct
4.1K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	21,750	-	-	Direct
Jul 1, 2026	RMTI ROCKWELL MEDICAL, INC.	Award(A)	9,633	-	$0	Direct
May 20, 2025	RMTI ROCKWELL MEDICAL, INC.	Award(A)	50,000	-	-	Direct
May 19, 2025	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	7,900	-	-	Direct
Nov 21, 2024	ELTX Elicio Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	4,100	-	-	Direct

1-5 of 5 transactions

About Nissenson Allen

Nissenson Allen (SEC CIK 0001441889) files insider reports with the SEC as Director of Elicio Therapeutics, Inc. (ELTX) and Director of ROCKWELL MEDICAL, INC. (RMTI).

Signal8 holds 5 ownership filings by Nissenson Allen, all Form 4s, filed between Nov 25, 2024 and Sep 2, 2026. Those filings report 5 transactions, from Nov 21, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nissenson Allen's filings is in BOSTON, MA.

Recent filings by Nissenson Allen

Aug 31, 2026: Grant or award of ELTX derivative securities (Form 4, code A).
Jul 1, 2026: Grant or award of RMTI shares (Form 4, code A).
May 20, 2025: Grant or award of RMTI shares (Form 4, code A).
May 19, 2025: Grant or award of ELTX derivative securities (Form 4, code A).
Nov 21, 2024: Grant or award of ELTX derivative securities (Form 4, code A).

Other insiders filing for Elicio Therapeutics, Inc. (ELTX)

ADAMS JULIAN, Director
Ashe Carol Gail, Director
Chudnovsky Yekaterina, Director
RUFFOLO ROBERT R, Director
WILSON KAREN J, Director
Venkatesan Jay, Director

How to read Form 4 transaction codes